As we discussed in this review, the upregulation of EpCAM and c-Met takes place in many human carcinomas and is in close relation to the development and propagation of cancers; thus, suppressing overexpression of EpCAM and c-Met may represent a potential potent therapeutic approach. The gene discussed is EPCAM; the disease is carcinoma.